OVA mRNA-LNP

Cat. No.: TDLD-0825-LD13

OVA mRNA-LNP

OVA mRNA-LNP is a state-of-the-art messenger RNA (mRNA) lipid nanoparticle (LNP) system, specifically engineered for efficient in vitro and in vivo protein expression. This LNP encapsulates mRNA encoding the model antigen Ovalbumin (OVA), serving as an excellent tool for studying immune responses, vaccine development, and antigen presentation mechanisms. Engineered with a proprietary lipid formulation for optimal mRNA encapsulation and delivery, it ensures high translation efficiency. We offer flexibility in lipid composition, including DLin-MC3-DMA, LP-01, ALC-0315, SM102, and targeted lipids for specific tissues (lung, liver, spleen, muscle), allowing for tailored delivery strategies. Our LNP ensures uniform particle size, high encapsulation efficiency, stability, and effective delivery. Applications of OVA mRNA-LNP include evaluating vaccine adjuvants, assessing T-cell and B-cell responses, studying antigen cross-presentation, and serving as a model system for immunotherapy research. Please note that this product is intended for research purposes only.